![]() |
![]() |
![]() |
![]() |
Nathalie Y. R. Agar, PhD | Clare M. Tempany, MD | Alexandra Golby, MD | Stephan E. Maier, MD, PhD |
![]() |
![]() |
![]() |
![]() |
Junichi Tokuda, PhD | Fiona M. Fennessy, MD, PhD | Sandro Santagata, MD, PhD | Filip Szczepankiewicz, PhD |
Led by Nathalie Agar, the focus areas for the Imaging Cancer Heterogeneity TRD are:
-
Integrating mass spectrometry imaging (MSI) of tissue metabolism, MRI, and histopathology for the assessment of brain tumor heterogeneity.
-
New diffusion imaging sequences to characterize cell architecture traits in prostate cancer.
-
New MRI pulse sequence for blood oxygenation mapping that accelerates acquisition speed more than ten-fold, without sacrificing volume coverage.